Key result
Inhibiting NLRP3-mediated pyroptosis shows promise against myocardial ischemia-reperfusion injury and ventricular remodeling.
Why the study?
Acute inflammatory injury and chronic heart failure after myocardial ischemia and reperfusion remain leading causes of death after AMI, with unclear mechanisms involving NLRP3 inflammasome activation and pyroptosis.
Answers are grounded in this paper and cite their sources.
Should not alter reperfusion strategies; leaves open NLRP3 inhibition as a research target pending trials.
Reperfusion therapy is the optimal therapy for acute myocardial infarction (AMI), but acute inflammatory injury and chronic heart failure (HF) after myocardial ischemia and reperfusion (MI/R) remain the leading cause of death after AMI. Pyroptosis, a newly discovered form of cell death, has been proven to play a significant role in the acute reperfusion process and the subsequent chronic process of ventricular remodeling. Current research shows that multiple stimuli activate the pyroptotic signaling pathway and contribute to cell death and nonbacterial inflammation after MI/R. These stimuli promote the assembly of the nucleotide-binding and oligomerization-like receptor pyrin domain-containing protein 3 (NLRP3) inflammasome by activating NLRP3. The mature NLRP3 inflammasome cleaves procaspase-1 to active caspase-1, which leads to mature processing of interleukin (IL)-18, IL-1ß, and gasdermin D (GSDMD) protein. That eventually results in cell lysis and generation of nonbacterial inflammation. The present review summarizes the mechanism of NLRP3 inflammasome activation after MI/R and discusses the role that NLRP3-mediated pyroptosis plays in the pathophysiology of MI/R injury and ventricular remodeling. We also discuss potential mechanisms and targeted therapy for which there is evidence supporting treatment of ischemic heart disease.
No takes yet. Share an insight, caveat, or question.
A 2021 study conducted a review in Myocardial ischemia-reperfusion injury and ventricular remodeling. NLRP3 inflammasome inhibitors was evaluated. NLRP3 inflammasome-mediated pyroptosis plays a crucial role in myocardial ischemia-reperfusion injury and ventricular remodeling, and inhibiting this pathway shows promise as a therapeutic target.
Synapse has enriched 10 related papers. Consider them for comparative context: